Literature DB >> 21439822

Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids.

Suzanne T Thomas1, Xinxin Yang, Nicole S Sampson.   

Abstract

The cholesterol metabolism pathway in Mycobacterium tuberculosis (M. tb) is a potential source of energy as well as secondary metabolite production that is important for survival of M. tb in the host macrophage. Oxidation and isomerization of 3β-hydroxysterols to 4-en-3-ones is requisite for sterol metabolism and the reaction is catalyzed by 3β-hydroxysteroid dehydrogenase (Rv1106c). Three series of 6-azasteroids and 4-azasteroids were employed to define the substrate preferences of M. tb 3β-hydroxysteroid dehydrogenase. 6-Azasteroids with large, hydrophobic side chains at the C17 position are the most effective inhibitors. Substitutions at C1, C2, C4 and N6 were poorly tolerated. Our structure-activity studies indicate that the 6-aza version of cholesterol is the best and tightest binding competitive inhibitor (K(i)=100 nM) of the steroid substrate and are consistent with cholesterol being the preferred substrate of M. tb 3β-hydroxysteroid dehydrogenase.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439822      PMCID: PMC3077731          DOI: 10.1016/j.bmcl.2011.03.004

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-one.

Authors:  Hugues Ouellet; Shenheng Guan; Jonathan B Johnston; Eric D Chow; Petrea M Kells; Alma L Burlingame; Jeffery S Cox; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Mol Microbiol       Date:  2010-06-10       Impact factor: 3.501

2.  6-Azasteroids: potent dual inhibitors of human type 1 and 2 steroid 5 alpha-reductase.

Authors:  S V Frye; C D Haffner; P R Maloney; R A Mook; G F Dorsey; R N Hiner; K W Batchelor; H N Bramson; J D Stuart; S L Schweiker
Journal:  J Med Chem       Date:  1993-12-24       Impact factor: 7.446

3.  Development of delta 5-3 beta-hydroxysteroid dehydrogenase activity in the interrenal gland of Rana catesbeiana.

Authors:  C Y Hsu; N W Yu; S J Chen
Journal:  Gen Comp Endocrinol       Date:  1980-10       Impact factor: 2.822

4.  Delta(5)-3beta-hydroxysteroid dehydrogenase from Digitalis lanata Ehrh. - a multifunctional enzyme in steroid metabolism?

Authors:  A Finsterbusch; P Lindemann; R Grimm; C Eckerskorn; M Luckner
Journal:  Planta       Date:  1999-10       Impact factor: 4.116

Review 5.  Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.

Authors:  Jacques Simard; Marie-Louise Ricketts; Sébastien Gingras; Penny Soucy; F Alex Feltus; Michael H Melner
Journal:  Endocr Rev       Date:  2005-01-04       Impact factor: 19.871

6.  6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase.

Authors:  S V Frye; C D Haffner; P R Maloney; R A Mook; G F Dorsey; R N Hiner; C M Cribbs; T N Wheeler; J A Ray; R C Andrews
Journal:  J Med Chem       Date:  1994-07-22       Impact factor: 7.446

7.  Expansion of the mammalian 3 beta-hydroxysteroid dehydrogenase/plant dihydroflavonol reductase superfamily to include a bacterial cholesterol dehydrogenase, a bacterial UDP-galactose-4-epimerase, and open reading frames in vaccinia virus and fish lymphocystis disease virus.

Authors:  M E Baker; R Blasco
Journal:  FEBS Lett       Date:  1992-04-13       Impact factor: 4.124

8.  Cloning, nucleotide sequence, and transcriptional analysis of the NAD(P)-dependent cholesterol dehydrogenase gene from a Nocardia sp. and its hyperexpression in Streptomyces spp.

Authors:  S Horinouchi; H Ishizuka; T Beppu
Journal:  Appl Environ Microbiol       Date:  1991-05       Impact factor: 4.792

9.  Ovarian 3 beta-hydroxysteroid dehydrogenase/delta 5-4-isomerase of rainbow trout: its cDNA cloning and properties of the enzyme expressed in a mammalian cell.

Authors:  N Sakai; M Tanaka; M Takahashi; S Fukada; J I Mason; Y Nagahama
Journal:  FEBS Lett       Date:  1994-08-22       Impact factor: 4.124

10.  Structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase by 6-azaandrost-4-en-3-ones: optimization of the C17 substituent.

Authors:  S V Frye; C D Haffner; P R Maloney; R N Hiner; G F Dorsey; R A Noe; R J Unwalla; K W Batchelor; H N Bramson; J D Stuart
Journal:  J Med Chem       Date:  1995-07-07       Impact factor: 7.446

View more
  8 in total

Review 1.  Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Trends Microbiol       Date:  2011-09-15       Impact factor: 17.079

2.  Ultrasound-Assisted Synthesis of Fluorescent Azatetracyclic Derivatives: An Energy-Efficient Approach.

Authors:  Gheorghita Zbancioc; Catalina-Ionica Ciobanu; Ionel I Mangalagiu; Costel Moldoveanu
Journal:  Molecules       Date:  2022-05-16       Impact factor: 4.927

Review 3.  More than cholesterol catabolism: regulatory vulnerabilities in Mycobacterium tuberculosis.

Authors:  Amber C Bonds; Nicole S Sampson
Journal:  Curr Opin Chem Biol       Date:  2018-06-12       Impact factor: 8.822

Review 4.  Cholesterol metabolism: a potential therapeutic target in Mycobacteria.

Authors:  Areej Abuhammad
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

Review 5.  Catabolism and biotechnological applications of cholesterol degrading bacteria.

Authors:  J L García; I Uhía; B Galán
Journal:  Microb Biotechnol       Date:  2012-02-07       Impact factor: 5.813

6.  Mce3R Stress-Resistance Pathway Is Vulnerable to Small-Molecule Targeting That Improves Tuberculosis Drug Activities.

Authors:  Xinxin Yang; Tianao Yuan; Rui Ma; Kieran I Chacko; Melissa Smith; Gintaras Deikus; Robert Sebra; Andrew Kasarskis; Harm van Bakel; Scott G Franzblau; Nicole S Sampson
Journal:  ACS Infect Dis       Date:  2019-05-03       Impact factor: 5.084

7.  Reductive Power Generated by Mycobacterium leprae Through Cholesterol Oxidation Contributes to Lipid and ATP Synthesis.

Authors:  Thabatta L S A Rosa; Maria Angela M Marques; Zachary DeBoard; Kelly Hutchins; Carlos Adriano A Silva; Christine R Montague; Tianao Yuan; Julio J Amaral; Georgia C Atella; Patrícia S Rosa; Katherine A Mattos; Brian C VanderVen; Ramanuj Lahiri; Nicole S Sampson; Patrick J Brennan; John T Belisle; Maria Cristina V Pessolani; Marcia Berrêdo-Pinho
Journal:  Front Cell Infect Microbiol       Date:  2021-07-28       Impact factor: 5.293

8.  Correlations among antral follicular echotexture, apoptosis and expression of key steroidogenic enzymes in sheep.

Authors:  Taylor Vanduzer; Raj Duggavathi; Maciej Murawski; Dorota A Zieba; Patrycja Sroka; Pawel M Bartlewski
Journal:  J Reprod Dev       Date:  2014-08-11       Impact factor: 2.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.